As cannabidiol (CBD) use rises, high-quality randomized clinical trials are needed to determine if anti-inflammatory benefits of CBD for heart disease seen in preclinical data will work in a real-world setting, according to research presented at ACC Latin America 2022. Read the article here.
High-quality human clinical trials needed to determine the benefits of CBD for heart disease patients
Source: News Medical
Click here to learn how STEM selects new articles.